Systematic Expression Profiling Analysis Identifies Specific MicroRNA-Gene Interactions that May Differentiate between Active and Latent Tuberculosis Infection

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wu, Lawrence Shih Hsin ^a   Lee, Shih Wei ^b,c   Huang, Kai Yao ^d   Lee, Tzong Yi ^d   Hsu, Paul Wei Che ^e   Weng, Julia Tzu Ya ^d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 107; MICRORNA 142 3P; MICRORNA 146A 5P; MICRORNA 150 5P; MICRORNA 16 5P; MICRORNA 21 5P; MICRORNA 22 3P; MICRORNA 221 3P; MICRORNA 223 3P; MICRORNA LET 7I 5P; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KNOWLEDGE BASE; LATENT TUBERCULOSIS; MOLECULAR DIAGNOSIS; MOLECULAR INTERACTION; MOLECULAR SYSTEMATICS; TAIWANESE; TUBERCULOSIS; UPREGULATION; BLOOD; CASE CONTROL STUDY; GENE REGULATORY NETWORK; GENETICS; REPRODUCIBILITY;

CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; LATENT TUBERCULOSIS; MICRORNAS; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 84930989482     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/895179     Document Type: Article

References (49)

1. V. Kumar and S. L. Robbins, Robbins Basic Pathology, Saunders/ Elsevier, 8th edition, 2007.
2. C. Dye and B. G. Williams, "The population dynamics and control of tuberculosis," Science, vol. 328, no. 5980, pp. 856-861, 2010.
3. I. Smith, "Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence," Clinical Microbiology Reviews, vol. 16, no. 3, pp. 463-496, 2003.
4. R. L. Skolnik, Global health 101, Jones & Barlett Learning, 2nd edition, 2012.
5. S. D. Lawn and A. I. Zumla, "Tuberculosis," The Lancet, vol. 378, no. 9785, pp. 57-72, 2011.
6. V. Herrera, S. Perry, J. Parsonnet, and N. Banaei, "Clinical application and limitations of interferon-γ release assays for the diagnosis of latent tuberculosis infection," Clinical Infectious Diseases, vol. 52, no. 8, pp. 1031-1037, 2011.
7. M. Jacobsen, D. Repsilber, A. Gutschmidt et al., "Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis," Journal of Molecular Medicine, vol. 85, no. 6, pp. 613-621, 2007.
8. P. Constantoulakis, E. Filiou, N. Rovina et al., "In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection," BMC Infectious Diseases, vol. 10, article 243, 2010.
9. L. M. Verhagen, A. Zomer, M. Maes et al., "A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children," BMC Genomics, vol. 14, no. 1, article 74, 2013.
10. J. Maertzdorf, D. Repsilber, S. K. Parida et al., "Human gene expression profiles of susceptibility and resistance in tuberculosis," Genes and Immunity, vol. 12, no. 1, pp. 15-22, 2011.
11. L. He and G. J. Hannon, "MicroRNAs: Small RNAs with a big role in gene regulation," Nature Reviews Genetics, vol. 5, no. 7, pp. 522-531, 2004.
12. R. J. Perera and A. Ray, "MicroRNAs in the search for understanding human diseases," BioDrugs, vol. 21, no. 2, pp. 97-104, 2007.
13. A. Liu, M. T. Tetzlaff, P. VanBelle et al., "MicroRNA expression profiling outperforms mRNA expression profiling in formalinfixed paraffin-embedded tissues," International Journal of Clinical and Experimental Pathology, vol. 2, no. 6, pp. 519-527, 2009.
14. S. Gilad, E. Meiri, Y. Yogev et al., "Serum microRNAs are promising novel biomarkers," PLoS ONE, vol. 3, no. 9, Article ID e3148, 2008.
15. A. Jackson and P. S. Linsley, "The therapeutic potential of microRNA modulation," Discovery Medicine, vol. 9, no. 47, pp. 311-318, 2010.
16. G. A. Calin and C. M. Croce, "MicroRNA signatures in human cancers," Nature Reviews Cancer, vol. 6, no. 11, pp. 857-866, 2006.
17. M. Ferracin, A. Veronese, and M. Negrini, "Micromarkers: MiRNAs in cancer diagnosis and prognosis," Expert Review of Molecular Diagnostics, vol. 10, no. 3, pp. 297-308, 2010.
18. F. Ma, S. Xu, X. Liu et al., "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ," Nature Immunology, vol. 12, no. 9, pp. 861-869, 2011.
19. C. H. Lecellier, P. Dunoyer, K. Arar et al., "A cellular microRNA mediates antiviral defense in human cells," Science, vol. 308, no. 5721, pp. 557-560, 2005.
20. K. Duskova, P. Nagilla, H.-S. Le et al., "MicroRNA regulation and its effects on cellular transcriptome in Human Immunodeficiency Virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts," BMC Infectious Diseases, vol. 13, no. 1, article 250, 2013.
21. C. Y. Lu, J. Wu, H. H. Wang et al., "Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells," PLoS ONE, vol. 6, no. 8,Article ID e24290, 2011.
22. Y. Fu, Z. Yi, X.Wu, J. Li, and F. Xu, "CirculatingmicroRNAs in patients with active pulmonary tuberculosis," Journal of Clinical Microbiology, vol. 49, no. 12, pp. 4246-4251, 2011.
23. C.Wang, S. Yang, G. Sun et al., "Comparative mirna expression profiles in individuals with latent and active tuberculosis," PLoS ONE, vol. 6, no. 10, Article IDe25832, 2011.
24. M. P. R. Berry, C. M.Graham, F.W.McNab et al., "An interferoninducible neutrophil-driven blood transcriptional signature in human tuberculosis," Nature, vol. 466, no. 7309, pp. 973-977, 2010.
25. H. Dweep, C. Sticht, P. Pandey, and N. Gretz, "MiRWalk-database: Prediction of possible miRNA binding sites by walking the genes of three genomes," Journal of Biomedical Informatics, vol. 44, no. 5, pp. 839-847, 2011.
26. J. B. Hsu, C.-M. Chiu, S.-D. Hsu et al., "MiRTar: An integrated system for identifying miRNA-target interactions in human," BMC Bioinformatics, vol. 12, article 300, 2011.
27. X. Wang, "miRDB: A microRNA target prediction and functional annotation database with a wiki interface," RNA, vol. 14, no. 6, pp. 1012-1017, 2008.
28. B. John, A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks, "Human microRNA targets," PLoS Biology, vol. 2, no. 11, article e363, 2004.
29. P. Loher and I. Rigoutsos, "Interactive exploration of RNA22 microRNA target predictions," Bioinformatics, vol. 28, no. 24, pp. 3322-3323, 2012.
30. B. P. Lewis, C. B. Burge, and D. P. Bartel, "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets," Cell, vol. 120, no. 1, pp. 15-20, 2005.
31. P. Flicek,M. R. Amode, D. Barrell et al., "Ensembl 2014," Nucleic Acids Research, vol. 42, pp. D749-D755, 2014.
32. D. Szklarczyk, A. Franceschini, M. Kuhn et al., "The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored," Nucleic Acids Research, vol. 39, no. 1, pp. D561-D568, 2011.
33. A. Franceschini, D. Szklarczyk, S. Frankild et al., "STRING v9.1: Protein-protein interaction networks, with increased coverage and integration," Nucleic Acids Research, vol. 41,no. 1, pp.D808-D815, 2013.
34. P. Shannon, A. Markiel, O. Ozier et al., "Cytoscape: A software environment for integrated models of biomolecular interaction networks," Genome Research, vol. 13, no. 11, pp. 2498-2504, 2003.
35. M. Kanehisa and S. Goto, "KEGG: Kyoto encyclopedia of genes and genomes," Nucleic Acids Research, vol. 28, no. 1, pp. 27-30, 2000.
36. S. V. Spinelli, A. Diaz, L. DAttilio et al., "Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response," Molecular Immunology, vol. 53, no. 3, pp. 265-269, 2013.
37. L. Furci, E. Schena, P. Miotto, and D. M. Cirillo, "Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosis," International Journal of Mycobacteriology, vol. 2, no. 3, pp. 128-134, 2013.
38. A. Dorhoi,M. Iannaccone,M. Farinacci, K. C. Fae, J. Schreiber, and P. Moura-Alves, "MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment," Journal of Clinical Investigation, vol. 123, pp. 4836-4848, 2013.
39. Q.-L. Meng, F. Liu, X.-Y. Yang et al., "Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3," BMC Microbiology, vol. 14, article 37, 2014.
40. K. Kleinsteuber, K. Heesch, S. Schattling et al., "Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T cells and peripheral blood from tuberculosis patients," PLoS ONE, vol. 8, no. 4,Article ID e61609, 2013.
41. D. A. Armstrong, J. A. Major, A. Chudyk, and T. A. Hamilton, "Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury," Journal of Leukocyte Biology, vol. 75, no. 4, pp. 641-648, 2004.
42. D. Jiang, T. Xie, J. Liang, and P. W. Noble, "beta-Arrestins in the immune system," Progress in Molecular Biology and Translational Science, vol. 118, pp. 359-393, 2013.
43. K. Loniewski, Y. Shi, J. Pestka, and N. Parameswaran, "Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages," Molecular Immunology, vol. 45, no. 8, pp. 2312-2322, 2008.
44. G. C. K. W. Koh, M. F. Schreiber, R. Bautista et al., "Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling," PLoS ONE, vol. 8, no. 1, Article ID e54961, 2013.
45. S. Mehra, B. Pahar, N. K. Dutta et al., "Transcriptional reprogramming in nonhuman primate (Rhesus Macaque) tuberculosis granulomas," PLoS ONE, vol. 5, no. 8, Article ID e12266, 2010.
46. R. Xia, Z. Hu, Y. Sun et al., "Overexpression of β-arrestin 2 in peripheral blood mononuclear cells of patients with cryptococcal meningitis," Journal of Interferon and Cytokine Research, vol. 30, no. 3, pp. 155-161, 2010.
47. J. Shen, R.Wan, G. Hua et al., "miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro," Pancreatology, vol. 12, no. 2, pp. 91-99, 2012.
48. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr., "A human homologue of the Drosophila toll protein signals activation of adaptive immunity," Nature, vol. 388, no. 6640, pp. 394-397, 1997.
49. K.Milde-Langosch, "TheFos family of transcription factors and their role in tumourigenesis," European Journal of Cancer, vol. 41, no. 16, pp. 2449-2461, 2005.